Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

H2al2y Inhibitors

H2al2y inhibitors constitute a specific class of chemical compounds meticulously designed to modulate the activity of the H2al2y protein. H2al2y, also known as histocompatibility 2, A region locus 2, Y subregion locus, is a protein found within the major histocompatibility complex (MHC) system, particularly in mice. The MHC system plays a pivotal role in the immune response by presenting antigenic peptides to T cells, enabling the immune system to recognize and respond to foreign pathogens effectively. H2al2y, like other MHC molecules, is intricately involved in the complex process of antigen presentation, a fundamental mechanism that allows the body to initiate immune responses against infections. The development of H2al2y inhibitors is primarily driven by the goal of selectively interacting with the H2al2y protein, potentially influencing its antigen-presenting activity and impacting immune recognition processes.

Typically, H2al2y inhibitors comprise small molecules or chemical compounds that are specifically engineered to bind to H2al2y, targeting either its active site or allosteric sites. This interaction can lead to the modulation of H2al2y's behavior, potentially affecting its ability to present antigenic peptides to T cells and, consequently, influencing the immune response against foreign antigens. Researchers are dedicated to unraveling the molecular mechanisms and functions of H2al2y within the MHC system, aiming to gain insights into the complex immune recognition processes. The development of H2al2y inhibitors represents an ongoing and dynamic area of research within the fields of immunology and molecular pharmacology, contributing significantly to our understanding of the immune system's functioning and its role in detecting and responding to foreign antigens.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Histone Lysine Methyltransferase Inhibitor Inhibitor

935693-62-2 (free base)sc-202651
5 mg
$151.00
4
(1)

A diazepin-quinazolin-amine derivative that inhibits G9a histone methyltransferase, potentially affecting gene transcription.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

A non-nucleoside DNA methyltransferase inhibitor, potentially leading to changes in gene expression patterns.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

A compound that binds to GC-rich sequences in DNA, potentially blocking transcription factor access and gene expression.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

A nucleoside analog that inhibits DNA methyltransferase, potentially resulting in hypomethylation and altered gene expression.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

Another nucleoside analog that incorporates into DNA and RNA, inhibiting DNA methyltransferase and affecting gene expression.

Fostriecin

87860-39-7sc-202160
50 µg
$265.00
9
(1)

A phosphate ester inhibitor of protein phosphatases 2A and 4, indirectly affecting transcription and gene expression.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

An isoflavone that has been observed to inhibit DNA methyltransferases, potentially affecting gene expression patterns.

Parthenolide

20554-84-1sc-3523
sc-3523A
50 mg
250 mg
$81.00
$306.00
32
(2)

A sesquiterpene lactone that can interfere with the NF-κB pathway and potentially influence gene transcription.

Oxamflatin

151720-43-3sc-205960
sc-205960A
1 mg
5 mg
$151.00
$470.00
4
(1)

A HDAC inhibitor that can change chromatin structure and affect transcription, potentially altering gene expression.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

A polyphenol that is thought to affect various signaling pathways and potentially modulate gene expression.